NuvaRing Blood Clot Lawsuits Filed Over DVT and Pulmonary Embolism

Three women from Texas have filed Nuvaring blood clot lawsuits against Organon and Merck & Co., the drug makers, alleging that the popular birth control ring caused them to suffer from a deep vein thrombosis (DVT), pulmonary embolism and other injuries. 

The Nuvaring lawsuits were filed on March 26 in the Marshall division of the Eastern District of Texas by Stephanie Huckabee, Amber Dawn Morgan and Christina Renee Pritchard. The women allege that the manufacturers failed to warn consumers about the risk of blood clots from side effects of NuvaRing.

According to a report in the Southeast Texas Record, the women claim that the drug makers down played the risk of problems from NuvaRing, marketing the birth control ring’s side effects as minimal. As a result of the failure to provide adequate and accurate warnings, Morgan alleges that she was hospitalized with deep vein thrombosis (DVT) after using the vaginal insertion ring for only a year and a half, Pritchard alleges that she suffered multiple DVTs after less than a year of use and Huckabee alleges she suffered both DVT and a pulmonary embolism from NuvaRing.

There are currently hundreds of similar lawsuits over NuvaRing blood clots that have been filed in various state and federal courts throughout the United States. As additional cases are reviewed and filed by NuvaRing lawyers, many anticipate that there could be thousands of cases eventually filed.

All of the cases involve similar allegations that Organon Pharmaceuticals failed to adequately research their birth control ring or warn about the potential for NuvaRing blood clot problems, including an increased risk of stroke, heart attack, pulmonary embolism, deep vein thrombosis (DVT) and sudden death.

More than 300 federal cases have already been consolidated for pretrial proceedings in an MDL, which is centralized in the U.S. District Court for the Eastern District of Missouri before District Judge Rodney W. Sipple. Parties on both sides have selected 13 lawsuits for an initial pool of bellwether cases, from which the first NuvaRing trials will be selected to gauge how juries will interpret evidence and witness testimony.